Related references
Note: Only part of the references are listed.撤稿声明: Correlation of Promoter Methylation in the MGMT Gene with Glioma Risk and Prognosis: a Meta-Analysis (Retraction of 2014)
Xiang Dong et al.
MOLECULAR NEUROBIOLOGY (2015)
Silencing of Suppressor of Cytokine Signaling-3 due to Methylation Results in Phosphorylation of STAT3 in Imatinib Resistant BCR-ABL Positive Chronic Myeloid Leukemia Cells
Hamid A. N. Al-Jamal et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Hydroxychloroquine Inhibits Autophagy to Potentiate Antiestrogen Responsiveness in ER+ Breast Cancer
Katherine L. Cook et al.
CLINICAL CANCER RESEARCH (2014)
Plastin Polymorphisms Predict Gender- and Stage-Specific Colon Cancer Recurrence after Adjuvant Chemotherapy
Yan Ning et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Inhibition of HDAC1 and DNMT1 Modulate RGS10 Expression and Decrease Ovarian Cancer Chemoresistance
Ercan Cacan et al.
PLOS ONE (2014)
Do epigenetic drug treatments hold the key to killing cancer progenitor cells?
Shannon Byler et al.
EPIGENOMICS (2014)
Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia
Brian Parkin et al.
BLOOD (2013)
Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance
Yulong Shang et al.
CURRENT CANCER DRUG TARGETS (2013)
Cancer Development, Progression, and Therapy: An Epigenetic Overview
Sibaji Sarkar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
Cory M. Johannessen et al.
NATURE (2013)
Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy
Sibaji Sarkar et al.
EPIGENOMICS (2013)
Telomere-Homologous G-Rich Oligonucleotides Sensitize Human Ovarian Cancer Cells to TRAIL-Induced Growth Inhibition and Apoptosis
Sibaji Sarkar et al.
NUCLEIC ACID THERAPEUTICS (2013)
Mechanisms and insights into drug resistance in cancer
Hiba Zahreddine et al.
FRONTIERS IN PHARMACOLOGY (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma
Elodie Begue et al.
BLOOD (2012)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
DNA repair dysregulation from cancer driver to therapeutic target
Nicola J. Curtin
NATURE REVIEWS CANCER (2012)
Inhibition of IGF1R activity enhances response to trastuzumab in HER-2-positive breast cancer cells
B. C. Browne et al.
ANNALS OF ONCOLOGY (2011)
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer
E. Razis et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
T-Oligos Inhibit Growth and Induce Apoptosis in Human Ovarian Cancer Cells
Sibaji Sarkar et al.
OLIGONUCLEOTIDES (2011)
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
Christine L. Chaffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
Rosalyn A. Juergens et al.
CANCER DISCOVERY (2011)
Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells
Kazuhito Sasaki et al.
BMC CANCER (2010)
Geldanamycin and its anti-cancer activities
Yayoi Fukuyo et al.
CANCER LETTERS (2010)
Contribution of BCR-ABL-independent activation of ERK1/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells
Takeru Nambu et al.
CANCER SCIENCE (2010)
Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O6-methylguanine-DNA methyltransferaseP140K
P. Maier et al.
GENE THERAPY (2010)
Inferring tumor progression from genomic heterogeneity
Nicholas Navin et al.
GENOME RESEARCH (2010)
Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer
Jean-Charles Soria et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Peter J. Campbell et al.
NATURE (2010)
Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression
M. K. Wendt et al.
ONCOGENE (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Selectins promote tumor metastasis
Heinz Laeubli et al.
SEMINARS IN CANCER BIOLOGY (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
β1-Integrin Circumvents the Antiproliferative Effects of Trastuzumab in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer
David Lesniak et al.
CANCER RESEARCH (2009)
The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis
Konstantinos A. Paschos et al.
CELLULAR SIGNALLING (2009)
Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs
Tsukasa Shibue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The selectin-selectin ligand axis in tumor progression
Isaac P. Witz
CANCER AND METASTASIS REVIEWS (2008)
Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton
Dalit Barkan et al.
CANCER RESEARCH (2008)
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function
Suleiman Massarweh et al.
CANCER RESEARCH (2008)
Enhancement of Cisplatin [cis-Diammine Dichloroplatinum (II)] Cytotoxicity by O6-Benzylguanine Involves Endoplasmic Reticulum Stress
Cara A. Rabik et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
5-fluorouracil: Mechanisms of resistance and reversal strategies
Ning Zhang et al.
MOLECULES (2008)
Oncogenic mutations of ALK kinase in neuroblastoma
Yuyan Chen et al.
NATURE (2008)
Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist
Ailsa J. Frew et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Constitutive overexpression of P-glycoprotein, rather than breast cancer resistance protein or organic cation transporter 1, contributes to acquisition of imatinib-resistance in k562 cells
Chie Hirayama et al.
PHARMACEUTICAL RESEARCH (2008)
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer
Katrien Berns et al.
CANCER CELL (2007)
Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17
Hongwu Shen et al.
DRUG METABOLISM AND DISPOSITION (2007)
Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines
Constanze Hilgendorf et al.
DRUG METABOLISM AND DISPOSITION (2007)
Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein
Kazuhiro Katayama et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells
Kazuyoshi Mutoh et al.
CANCER SCIENCE (2006)
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A. Olaussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma
M Haber et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial
D Sampath et al.
BLOOD (2006)
Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer
JF Gagnon et al.
CLINICAL CANCER RESEARCH (2006)
Cytochrome P450 pharmacogenetics and cancer
C Rodriguez-Antona et al.
ONCOGENE (2006)
beta(3) Integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells
Amy J. Galliher et al.
BREAST CANCER RESEARCH (2006)
Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR
DW Bell et al.
NATURE GENETICS (2005)
Complement-mediated mechanisms in anti-GD2 monoclonal antibody therapy of murine metastatic cancer.
M Imai et al.
CANCER RESEARCH (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
S Kobayashi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Tumoral drug metabolism: Overview and its implications for cancer therapy
M Michael et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor β but not the estrogen receptor αgene
HG Chang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Predicting drug sensitivity and resistance:: Profiling ABC transporter genes in cancer cells
G Szakács et al.
CANCER CELL (2004)
Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas
JL Blanc et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer
J Shou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
The rise of DNA methylation and the importance of chromatin on multidrug resistance in cancer
EK Baker et al.
EXPERIMENTAL CELL RESEARCH (2003)
The role of glutathione-S-transferase in anti-cancer drug resistance
DM Townsend et al.
ONCOGENE (2003)
Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines
CN Arnold et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
The role of AKT and RAFTK in β1 integrin mediated survival of precursor B-acute lymphoblastic leukemia cells
S Sarkar et al.
LEUKEMIA & LYMPHOMA (2002)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells
J Worm et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
被撤回的出版物: Structure of MsbA from E-coli:: A homolog of the multidrug resistance ATP binding cassette (ABC) transporters (Retracted Article. See vol 314, pg 1875, 2006)
G Chang et al.
SCIENCE (2001)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1
RC Cumming et al.
NATURE MEDICINE (2001)
Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein - The two ATP hydrolysis events in a single catalytic cycle are kinetically similar but affect different functional outcomes
ZE Sauna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes
M Esteller
EUROPEAN JOURNAL OF CANCER (2000)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Xenobiotic-metabolizing cytochromes P450 convert prostaglandin endoperoxide to hydroxyheptadecatrienoic acid and the mutagen, malondialdehyde
JP Plastaras et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
